Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02675855 · ClinicalTrials.gov registry record · Phase 4
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
A Phase 4 study, sponsored by Osiris Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT02675855: Completed Phase 4 study, sponsored by Osiris Therapeutics.
NCT02675855 is a Phase 4 study that has completed, run by Osiris Therapeutics. The registered enrollment target is 75 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02675855, a Phase 4 study, has completed, sponsored by Osiris Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
The objective of the study is to compare the efficacy of weekly GrafixPRIME® administration to an Active Comparator in patients with chronic DFUs in a randomized, single-blind study.
Interventions
- PROCEDURE Dressing Application
- OTHER GrafixPRIME®
- DEVICE Off-loading (walking boot)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-07 |
| Phase | Phase 4 |
What the finished NCT02675855 record still lists
NCT02675855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which Dressing Application is the first listed.
NCT02675855 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02675855 about?
NCT02675855 is a clinical study titled "GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers". The objective of the study is to compare the efficacy of weekly GrafixPRIME® administration to an Active Comparator in patients with chronic DFUs in a randomized, single-blind study.
What is the current status of trial NCT02675855?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2016-01. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02675855?
The interventions under investigation include: Dressing Application (PROCEDURE), GrafixPRIME® (OTHER), Off-loading (walking boot) (DEVICE).
Who is sponsoring clinical trial NCT02675855?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02675855's enrollment target sits among peer trials
75 1002nd of 2000 higher than 974 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia